CONMED CORPORATION Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CONMED CORPORATION treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $6.26M.
- CONMED CORPORATION treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $37.39M.
- CONMED CORPORATION treasury stock, value, acquired, cost method for fiscal 2014 was $16.86M, a 66.65% decline from fiscal 2013.
- CONMED CORPORATION treasury stock, value, acquired, cost method for fiscal 2013 was $50.56M, a 1188.71% increase from fiscal 2012.
- CONMED CORPORATION treasury stock, value, acquired, cost method for fiscal 2012 was $3.92M, a 73.88% decline from fiscal 2011.
- CONMED CORPORATION treasury stock, value, acquired, cost method for fiscal 2011 was $15.02M, a 34.63% decline from fiscal 2010.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $6.26M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $37.39M 10-Q · filed 2026-07-29 | |
| 2014-12-31 | $16.86M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $50.56M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $3.92M 10-K · filed 2015-02-23 | |
| 2011-12-31 | $15.02M 10-K · filed 2014-02-24 | |
| 2010-12-31 | $22.98M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |